Objectives: A previous study identified an association between high MICs of quaternary ammonium compounds (QACs) and antibiotic resistance. The current aim was to investigate the genetic background of this association.
Introduction
The emergence of Escherichia coli isolates with multidrugresistant (MDR) phenotypes, including co-resistance to four or more unrelated families of antibiotics and/or disinfectants, has been reported and is considered a serious health issue. 1 In recent years, there have been increasing concerns that quaternary ammonium compound (QAC) exposure may help drive selection of antibiotic-resistant bacteria. Antibiotic and QAC resistance genes, i.e. qacE or qacED1, are both carried on class 1 integrons. Class 1 integrons consist of a 5 ′ -conserved segment (5 ′ CS), variable regions containing the cassette genes and a 3 ′ -conserved segment (3 ′ CS). 2 Alternatively, acquisition of an MDR phenotype in E. coli has also been linked to AcrAB overexpression. 3 -5 In E. coli, seven homologous resistance-nodulation -cell division (RND)-type pumps are known. The tripartite AcrAB-TolC complex appears to be expressed constitutively at high levels and contributes significantly to the intrinsic resistance of E. coli to a number of antibiotics. 6 The mar locus is known to encode the marRAB operon, specifying the repressors MarR and MarA, SoxS and Rob, which positively regulate the operon and affect AcrAB expression. 7 Pharmacological inhibition of MDR efflux pumps might be an attractive goal for reversing drug resistance in E. coli species and to improve therapy options. Phenyl-arginine-b-naphthylamide (PAbN) has been reported to be a broad-spectrum efflux pump inhibitor (EPI) capable of reversing the MDR phenotype of Gramnegative bacteria. 8 In a previous study, 9 we demonstrated an epidemiological relationship between high MIC values of QACs and antibiotic # The Author 2012. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com J Antimicrob Chemother 2012; 67: 2837 -2842 doi:10.1093/jac/dks321 Advance Access publication 17 August 2012 resistance in 153 clinical E. coli isolates. In multivariate analysis, antibiotic susceptibility to co-trimoxazole (trimethoprim/sulfamethoxazole) was independently associated with the alkyl dimethyl benzyl ammonium chloride (ADBAC) MIC (≤16 mg/L) and the dodecyl dimethyl ammonium chloride (DDAC) MIC (≤8 mg/L), and antibiotic susceptibility to co-trimoxazole was also associated with susceptibility to amoxicillin and to nalidixic acid (P,0.05).
The aim of the present study was to investigate in seven clinical isolates selected for their low or high MICs of antibiotics and/ or QACs 9 (plus two reference E. coli strains) (i) the expression and occurrence of structural changes in genes encoding the AcrA/ TolC efflux pump and its regulatory proteins MarA, MarOR, SoxS and Rob and (ii) the presence of integrons and their gene cassette content. We also used a phenotypic approach (comparison of MICs in the presence and absence of PAbN) to determine the exact nature of the resistance mechanism and connect the susceptibility and genetic results already obtained.
Materials and methods
Bacterial strains, antibiotic susceptibility testing and MICs of QACs in the presence or absence of PAbN Out of 153 E. coli isolates, 9 seven clinical isolates were selected for their low (strains 3 and 4) or high (strains 5-9) MICs of amoxicillin, co-trimoxazole and/or QACs (see Table 2 ). Broth and agar were obtained from AES (AES Laboratory, Combourg, France) and ADBAC and DDAC from Laboratoire Anios (France). E. coli ATCC 14536 (strain 1) and E. coli K12DH10B (strain 2) were used as test strains for MIC determination, in RT-PCR for relative quantification of expression and for DNA sequencing. E. coli harbouring intI1, intI2 and intI3 were kindly provided by T. M. Coque and colleagues. Susceptibilities to a panel of different antibiotics were studied by the Etest method (bioMérieux, France) on Mueller-Hinton agar in the presence or absence of PAbN 8 (100 mg/L; Sigma, France), in accordance with the CLSI and the recommendations of the European Committee on Antibiotic Susceptibility Testing (EUCAST-2011; http ://www.eucast.org/clinical_breakpoints/). In the absence of recommendations for breakpoints for streptomycin for Enterobacteriaceae, given in EUCAST-2011, the streptomycin epidemiological cut-off value for E. coli was determined as previously recommended (≤8 mg/L).
10,11 The antibiotics tested included amoxicillin, amoxicillin/clavulanic acid, imipenem, cefotaxime, streptomycin, spectinomycin, amikacin, ciprofloxacin and co-trimoxazole. As previously described, 9 microdilution tests were performed in Mueller-Hinton agar to determine the MIC of ADBAC or DDAC. A 4-fold or greater reduction in MIC values after the addition of PAbN was considered significant. 8 DNA, PCR and sequencing DNA was extracted using the DNAeasy kit (Qiagen, Courtaboeuf, France). Different PCR mapping experiments were performed using the primer sets described in Table 1 . All PCRs were performed using 5× first-strand reaction buffer, 10 mM of each deoxynucleoside triphosphate, 10 mM of each primer in the set and 2 units/mL of Taq DNA polymerase (Finnzymes, Saint Quentin, France). The first amplification programme to search for the presence of mutations that might affect acrA or tolC and the regulatory genes marA, marOR, soxS or rob was 45 s at 988C and 30 cycles of 10 s at 988C, 30 s at 608C and 45 s at 728C, with a final extension step of 10 min at 728C. The amino acid sequences of AcrA, TolC, MarA, MarO, MarR, SoxS and Rob encoded by eight E. coli strains (strains 1 and 3 -9) were compared with E. coli K12DH10B (strain 2). The second amplification programme to detect intI1-, intI2-or intI3-positive samples was 45 s at 988C and 30 cycles of 10 s at 988C, 30 s at 618C (intI1) or 648C (intI2 and intI3) and 45 s at 728C, with a final extension step of 10 min at 728C. The third amplification programme to search for associated gene cassette regions and Pc-P2 promoter sequences was 45 s at 988C and 30 cycles of 10 s at 988C, 30 s at 598C and 45 s at 728C, with a final extension step of 10 min at 728C. Amplified products underwent bidirectional sequencing using the BigDye terminator (Applied Biosystems, Courtaboeuf, France). The PCR programme for all sequencing reactions included 25 cycles of 10 s at 968C, 5 s at 508C and 45 min at 
RNA and RT-PCR
An overnight culture was diluted 1 : 100 in Mueller-Hinton broth and grown to the late log phase of growth (2 h at 378C). RNA was extracted and treated with DNase using the RNeasy kit (Qiagen). Contaminating genomic DNA was digested by DNase (RNase-Free DNase Set, Qiagen) for 30 min at 308C. RNA yield and quality were measured using the Nanodrop 2000 spectrophotometer (Thermo Scientific, Courtaboeuf, France) and Bioanalyzer 2100 (Agilent, Garches, France). cDNAs were synthesized from 0.5 mg of RNA template using the Quantitect Reverse Transcription Kit according to the manufacturer's instructions (Qiagen). Table 1 gives the primers used. RT-PCR conditions were 2 min at 258C and 90 min at 428C. Relative quantification of acrA, tolC, marA, marOR, soxS and rob was performed using StepOnePlus (Applied Biosystems) with the SYBR Green PCR Master Mix (Applied Biosystems). Fold-change values were calculated after normalization of each gene to the 16S rRNA internal control, using the comparative threshold method with E. coli ATCC 14536 (strain 1) as the reference strain. 13 Each sample was run in triplicate. Changes in gene expression were considered relevant only if there was at least a 2-fold change compared with the reference strain, and significant if a t-test had a P value ≤0.05, as described previously. 14 
Bioinformatics tools
Multiple sequences were aligned using Clustal W (http://www.ebi.ac.uk/ clustalw/index.html).
Sequences were compared with E. coli K12DH10B (strain 2). To search for associated gene cassette regions, homology searches were carried out using BLAST (http://www.ncbi.nlm.nih.gov/) and GENEIOUS (http:// www.geneious.com).
Results

Antimicrobial susceptibility
Cross-resistance among amoxicillin, amoxicillin/clavulanic acid and co-trimoxazole and high-level MICs of QACs were observed for strains 5, 6 and 7. Strain 8 was resistant to amoxicillin, amoxicillin/clavulanic acid, co-trimoxazole and ciprofloxacin and had low-level MICs of QACs, in contrast to strain 9, which was antibiotic susceptible and had high-level MICs of QACs. Resistance to spectinomycin was observed only for strain 8. Resistance to streptomycin was observed for strains 2, 6, 7 and 8. Strains 5, 6 and 8 were resistant to fluoroquinolones (Table 2 ). PAbN at a concentration of 100 mg/L had various effects on the MICs of the test drugs (Table 2) , reducing the MICs of ciprofloxacin by 2-fold or more in strains 5, 6 and 8. Particularly strong effects with PAbN at 100 mg/L were observed with ADBAC and DDAC. In contrast, PAbN was unable to reduce the MIC of amoxicillin, amoxicillin/clavulanic acid, spectinomycin, streptomycin or cotrimoxazole (Table 2) .
Integrons
The four amoxicillin-and co-trimoxazole-resistant strains (5 -8) harboured class 1 integrons containing different cassettes. Class 1 integrons were found with identity to genes encoding Table 2 . site-specific integrase (intI1), dihydrofolate reductase A (dfrA, trimethoprim resistance), aminoglycoside adenylyltransferase A (aadA, streptomycin/spectinomycin resistance), deleted derivative QACs (qacED1, low-level resistance to antiseptics and disinfectants) and sulphonamides (sul1, sulphonamide resistance). Strains 5 and 8 contained an arrangement consisting of a module drfA1-aadA1-qacED1-sul1; strain 7 an arrangement of dfrA17-aadA5-qacED1-sul1; and strain 6 a truncated intI1 gene cassette (Figure 1) . Table 2 and Figure 1 show the associations among antibiotic resistance, QAC MICs and detection of class 1 integrons. The presence of cassettes coding for high MICs of antimicrobial agents was demonstrated among strains 5, 7 and 8 for co-trimoxazole (dfrA/sul1) and among strains 5 and 7 for QACs (qacED1). Although strains 5, 7 and 8 contained a class 1 integron that harboured a streptomycin/spectinomycin resistance gene (aadA), only strain 8 was resistant to streptomycin/spectinomycin and strain 7 to streptomycin. In class 1 integrons, promoter Pc combined with promoter P2 drove the expression of cassette genes. Strains 5, 7 and 8 contained a Pc weak 235 TGGACA and 210 TAAGCT spaced from 17 bp and an inactive P2 promoter 235 TTGTTA and 210 TACAGT spaced from 14 bp. Class 2 or 3 integrons were not detected in any of the strains studied. Strains susceptible to co-trimoxazole, amoxicillin, amoxicillin/clavulanic acid, cefotaxime, imipenem, amikacin and ciprofloxacin did not carry class 1 integrons. Despite the fact that the MICs of QACs were high in strain 9, this strain did not carry any class 1 integron and thus no qacED1 gene cassette.
Efflux pumps
Resistance to antibiotics and high MICs of QACs may be based on an active export mechanism by efflux pumps. The expression and the integrity of coding sequences of the pumps, like those of their regulators and promoters, were assayed. Known regulators of the AcrAB-TolC efflux pump include the regulatory genes marA, marO, marR, soxS and rob. 3, 15, 16 Sequencing of these genes was first performed to detect some mutations potentially responsible for variations in gene expression. Table 3 shows the amino acid sequences of AcrA, TolC, MarA, MarO, MarR, SoxS and Rob. The same mutation A T was located in the amino acid sequence of TolC in strains 3, 5, 7 and 8 and did not increase the tolC expression in comparison with strain 1 (Tables 2 and 3) . A similar observation was made for the point mutation T A detected in the amino acid sequence of AcrA. The same mutations (G S; Y H) were detected in the sequence of MarR in all strains except strain 2. Another mutation point, S N, in the sequence of MarR was located in strains 5 and 7, but did not increase the marOR expression in comparison with strain 1 (Tables 2 and 3) . No amino acid mutations in MarO or SoxS were detected, and a single mutation L Q located in the sequence of MarA in strain 7 was identified. No changes in nucleotide positions within marO sites I and II and 'marbox' were detected. The same mutation A C in the 'accessory marbox region' within marO was located in 1332 for eight strains (1 and 3 -9). None of the mutations detected in the amino acid sequences of AcrA, TolC, MarA, MarO, MarR, Rob and SoxS could explain fluctuations in marRAB gene expression ( Table 2 ).
The next step was RT-PCR to analyse expression of genes coding the pump AcrAB/TolC and its main regulators. None of the susceptible strains overexpressed any genes. Expression of acrA remained constant for all tested strains whether or not they were resistant to antibiotics and/or the level of MICs of QACs. Indeed, the five clinically resistant strains (strains 5 -9) always overexpressed tolC and marOR genes ( Table 2) . Overexpression of tolC correlated with resistance to amoxicillin, amoxicillin/clavulanic acid and co-trimoxazole and/or high-level MICs of QACs. In strain 9, which was susceptible to antibiotics, higher MICs of QACs were related to overexpression of tolC, marA, marOR and rob.
Discussion
Most studies demonstrating a relationship between resistance to antibiotics and disinfectants have been performed on laboratory Figure 1 . PCR map of the integron structure in the E. coli strains 5 -8. Represented genes are: intI1, site-specific integrase; dfrA, trimethoprim-resistant dihydrofolate reductase; aadA, streptomycin and spectinomycin resistance gene; qacED1, deleted derivative qacE associated with low-level resistance to antiseptics and disinfectants; and sul1, sulphonamide resistance gene. In the 5 ′ CS of integrons, the promoter Pc (black arrow) consists of a 235 region TGGACA separated by 17 bases from a 210 region TAAGCT and the secondary promoter P2 (white chevron) consists of a 235 region TTGTTA separated by 14 bases from a 210 region TACAGT.
strains or mutants, often in the presence of antibiotics or disinfectants. 17 Here the mechanism of resistance to antibiotics and of high MICs of QACs was studied in E. coli clinical isolates without exposing them in vitro to increasing antibiotic or QAC concentrations.
Integrons
Class 1 integrons were characterized by two conserved segments, 5 ′ CS and 3 ′ CS, that flank the variable gene cassette region. The 5 ′ CS region containing the potential promoter Pc allows expression of the inserted cassette genes. Pc -P2 combinations were Pc weak and P2 inactive. The weaker the promoter is, the stronger the integrase. 12 The variable region consisted of dfrA and aadA gene cassettes affecting trimethoprim (dfrA), streptomycin and spectinomycin (aadA). The 3 ′ CS of class 1 integrons contained qacED1 and sul1, which mediate low-level resistance to QACs (qacED1 encodes an efflux pump belonging to the small multidrug resistance family) and to sulfamethoxazole (sul1). 18 In this study, the presence of dfrA/sul1 and qacED1 gene cassettes was linked, respectively, to resistance to co-trimoxazole and high MICs of QACs for three of four integron-positive strains. This result was not unexpected. We have previously reported that high MICs of QACs for clinical E. coli were associated with antibiotic resistance to co-trimoxazole and strongly associated with susceptibility to amoxicillin and nalidixic acid (P,0.01). 9 Among strains 5, 6, 7 and 8, resistant to amoxicillin, and 5, 6 and 8, resistant to ciprofloxacin, none harboured genes encoding resistance to b-lactams (bla TEM , bla SHV-1 , bla OXA-1 and bla PSE-1 ) or to fluoroquinolones (qnrA) within the class 1 integron. 19, 20 The presence of the aadA gene cassette was related to high MICs of spectinomycin for strains 5, 7 and 8. Several resistance mechanisms have been demonstrated for isolates harbouring high streptomycin MICs.
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Efflux pumps
The overexpression of tolC in strains with high MICs of antibiotics and/or QACs was unsurprising given previous evidence showing that strains deleted for tolC exhibit hypersusceptibility to various antibiotics and ADBAC. 6 As a consequence, TolC is considered a major element of the efflux pump system directly involved in antimicrobial multiresistance. 21 Transcriptional activators such as MarA, SoxS and MarR have been shown to regulate the expression of the AcrAB-TolC efflux pump. Overexpression of tolC, marA, marOR, soxS and rob was observed in strains with high MICs of antibiotics and/or QACs. Our report did not find any mutation or deletion in the MarA or MarR binding sites previously described in the increase of MICs of antibiotics and/or QACs. 16 At 100 mg/L, PAbN reduced the MIC of ciprofloxacin and QACs, but remained ineffective in reducing the MIC of amoxicillin, amoxicillin/clavulanic acid, spectinomycin, streptomycin and cotrimoxazole. PAbN had effects on fluoroquinolone MICs for E. coli, a finding consistent with a report by Kern et al. 8 The poor activity of PAbN on b-lactam and aminoglycoside MICs for strains has also been reported by Kern et al. 8 However, the ability of PAbN to reduce the MICs of the two QACs, ADBAC and DDAC, is remarkable and has not previously been reported. Moreover, PAbN, as a known competitive inhibitor of RND efflux pumps, could explain the association between high MICs of fluoroquinolones and QACs and overexpression of tolC and its regulators. 22 In a study by O'Regan et al., 23 both soxS and marA were overexpressed in an in vitro-derived ciprofloxacin-resistant mutant. 
JAC
In conclusion, the findings of the present study demonstrate different resistance mechanisms connected to the susceptibility tests and genetic investigation. High MICs of ciprofloxacin and QACs were related to overexpression of tolC and its regulators, a finding demonstrated by the capacity of the EPI PAbN to reduce the MICs of ciprofloxacin and QACs. The same efflux pumps can be used in the presence of various antimicrobial agents, and their expression can induce extrusion of several different molecules and then participation in MDR mechanisms. As a result, development of a means to circumvent or block specific efflux mechanisms could lead to important innovations in treating infectious disease agents. The dfrA/sul1 and qacED1 gene cassettes within the class 1 integron were associated with high MICS of QACS and of co-trimoxazole, indicating that we should be aware that the integration of gene cassettes conferring resistance to antimicrobial agents in integrons is likely to be only a matter of time. These results emphasize the need to promote new biocide regulation.
